Diabetes Mellitus and Autoimmune Hepatitis: Demographical and Clinical Description of a Relatively Rare Phenotype

Abstract

We studied demographic, metabolic, and clinical characteristics of patients with diabetes and autoimmune hepatitis (AIH) from the German/Austrian DPV registry. A total of 139 patients with diabetes and AIH were analyzed and compared to 437 728 patients with diabetes without AIH. The prevalence of AIH in patients with T1DM (44.8/100 000) seems higher than in the general population, the prevalence of AIH in patients with T2DM (23.6/100 000) does not seem to be increased. Patients with T2DM and AIH had a shorter duration of diabetes (p=0.007) and a higher proportion of females (p<0.001) compared to T2DM without AIH. Patients with diabetes (T1DM or T2DM) and AIH required higher insulin doses (p<0.001 and p=0.03, respectively) and showed increased liver enzymes (aspartate transaminase, alanine transaminase, gamma-glutamyltransferase) compared to diabetes patients without (all p<0.001). We detected a lower percentage of patients treated with oral antidiabetic drugs (p=0.01) and a higher percentage of patients treated by insulin in patients with T2DM and AIH (p<0.001) compared to patients with T2DM alone. We observed a higher incidence of autoimmune thyroid disease (AIT) in patients with diabetes (T1DM or T2DM) and AIH (p<0.001) compared to diabetes patients without AIH. AIH seems more frequent in patients with T1DM. Patients with diabetes and AIH require intensification of antidiabetic therapy and seem to have a higher prevalence of AIT.

Key words

type 1 diabetes - type 2 diabetes - autoimmune thyroid disease - clinical outcome - diabetes treatment

• References

• 1 Al-Hussaini AA, Alzahrani MD, Alenizi AS, Suliman NM, Khan MA, Alharbi SA, Chentoufi AA. Autoimmune hepatitis related autoantibodies in children with type 1 diabetes. Diabetol Metab Syndr 2014; 6: 38
• 2 Umpierrez GE, Latif KA, Murphy MB, Lambeth HC, Stentz F, Bush A, Kitabchi AE. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care 2003; 26: 1181-1185
• 3 Gillett PM, Gillett HR, Israel DM, Metzger DL, Stewart L, Chanoine JP, Freeman HJ. High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase. Can J Gastroenterol 2001; 15: 297-301
• 4 Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M, Eisenbarth GS. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease associated transglutaminase autoantibodies. J Autoimmun 1999; 13: 143-148
• 5 Yu L, Brewer KW, Gates S, Wang T, Babu S, Gottlieb PA, Freed BM, Noble J, Erlich HA, Eisenbarth GS. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison’s disease. J Clin Endocrinol Metab 1999; 84: 328-335
• 6 Hovinga IC, Stam ED, Mearin ML, Mul D. A girl with type 1 diabetes and a yellowish appearance. BMJ Case Rep 2010; 26: 1-4
• 7 De Block CE, De Leeuw IH, Pelckmans PA, Michielsen PP, Bogers JJ, Van Marck EA, Van Gaal LF. Autoimmune hepatitis, autoimmune gastritis, and gastric carcinoid in a type 1 diabetic patient: a case report. J Diabetes Complications 2000; 14: 116-120
• 8 Sotelo-Cruz N, López-Cervantes G, Campbell-Araujo OA. Immunological disorders: (Type 1 Diabetes, Idiopathic Thrombocytopenic Purpura and Hashimoto Encephalopathy), Associated with Autoimmune Hepatitis. Immunome Res 2015; 11: 2
• 9 Nastasio S, Sciveres M, Riva S, Filippeschi IP, Vajro P, Maggiore G. Celiac disease-associated autoimmune hepatitis in childhood: long-term response to treatment. J Pediatr Gastroenterol Nutr 2013; 56: 671-674
• 10 Dieli-Crimi R, Núñez C, Estrada L, López-Palacios N. An autoimmune polyglandular syndrome complicated with celiac disease and autoimmune hepatitis. Ann Hepatol 2016; 15: 588-591
• 11 Hemminki K, Liu X, Försti A, Sundquist J, Sundquist K, Ji J. Subsequent type 2 diabetes in patients with autoimmune disease. Sci Rep 2015; 5: 13871
• 12 Solomon DH, Love TJ, Canning C, Schneeweiss S. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 2010; 69: 2114-2117
• 13 Dubreuil M, Rho YH, Man A, Zhu Y, Zhang Y, Love TJ, Ogdie A, Gelfand JM, Choi HK. Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology 2014; 53: 346-352
• 14 Soloway RD, Summerskill WH, Baggenstoss AH, Geall MG, Gitnićk GL, Elveback IR, Schoenfield LJ. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972; 63: 820-833
• 15 Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971; 40: 159-185
• 16 Yoneyama K, Honda E, Kogo M, Kiuchi Y, Shibata M, Mitamura K, Inawari M. Efficacy and safety of prednisolone in patients with autoimmune hepatitis. Adv Ther 2006; 23: 74-91
• 17 Warncke K, Fröhlich-Reiterer EE, Thon A, Hofer SE, Wiemann D, Holl RW. DPV Initiative of the German Working Group for Pediatric Diabetology; German BMBF Competence Network for DiabetesMellitus . Polyendocrinopathy in children, adolescents, and young adults with type 1 diabetes: a multicenter analysis of 28,671 patients from the German/Austrian DPV-Wiss database. Diabetes Care 2010; 33: 2010-2012
• 18 Bechtold S, Blaschek A, Raile K, Dost A, Freiberg C, Askenas M, Fröhlich-Reiterer E, Molz E, Holl RW. Higher relative risk for multiple sclerosis in a pediatric and adolescent diabetic population: Analysis from DPV database. Diabetes Care 2014; 37: 96-101
• 19 Rosenbauer J, Dost A, Karges B, Hungele A, Stahl A, Bächle C, Gerstl EM, Kastendieck C, Hofer SE, Holl RW. DPV Initiative and the German BMBF Competence Network Diabetes Mellitus. Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care 2012; 35: 80-86
• 20 Francque S, Vonghia L, Ramon A, Michielsen P. Epidemiology and treatment of autoimmune hepatitis. Hepat Med 2012; 4: 1-10
• 21 Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 2002; 6: 635-647
• 22 Jiménez-Rivera C, Ling SC, Ahmed N, Yap J, Aglipay M, Barrowman N, Graitson S, Critch J, Rashid M, Ng VL, Roberts EA, Brill H, Dowhaniuk JK, Bruce G, Bax K, Deneau M, Guttman OR, Schreiber RA, Martin S, Alvarez F. Incidence and characteristics of autoimmune hepatitis. Pediatrics 2015; 136: e1237-e1248
• 23 Kim BH, Choi HY, Ki M, Kim KA, Jang ES, Jeong SH. Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea. PLoS One 2017; 12: e0182391
• 24 Ngu JH, Bechly K, Chapman BA, Burt MJ, Barclay ML, Gearry RB, Stedman CA. Population-based epidemiology study of autoimmune hepatitis: a disease of older women?. J Gastroenterol Hepatol 2010; 25: 1681-1686
• 25 Teufel A, Weinmann A, Kahaly GJ, Centner C, Piendl A, Wörns M, Lohse AW, Galle PR, Kanzler S. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol 2010; 44: 208-213
• 26 da Silva ME, Porta G, Goldberg AC, Bittencourt PL, Fukui RT, Correia MR, Miura IK, Pugliese RS, Baggio VL, Cançado EL, Kalil J, Santos RF, Rochal DM, Wajchenberg BL, Ursich MJ, Rosenbloom AL. Diabetes mellitus-related autoantibodies in childhood autoimmune hepatitis. J Pediatr Endocrinol Metab 2002; 15: 831-840
• 27 Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, Mowat AP, Vergani D, Mieli-Vergani G. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997; 25: 541-547
• 28 Heras P, Mantzioros M, Mendrinos D, Heras V, Hatzopoulos A, Xourafas V, Kritikos K, Karagiannis S. Autoantibodies in type 1 diabetes. Diabetes Res Clin Pract 2010; 90: e40-e42
• 29 Cindoruk M, Yetkin I, Karakan T, Kandilci U. The prevalence of autoimmune hepatitis in Hashimoto's thyroiditis in a Turkish population. Acta Gastroenterol Belg 2002; 65: 143-145
• 30 Caprai S, Vajro P, Ventura A, Sciveres M, Maggiore G. SIGENP Study Group for Autoimmune Liver Disorders in Celiac Disease . Autoimmune liver disease associated with celiac disease in childhood: a multicenter study. Clin Gastroenterol Hepatol 2008; 6: 803-806
• 31 Peng M, Li Y, Zhang M, Jiang Y, Xu Y, Tian Y, Peng F, Gong G. Clinical features in different age groups of patients with autoimmune hepatitis. Exp Ther Med 2014; 7: 145
• 32 Neufeld M, Maclaren N, Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann 1980; 9: 154-162
• 33 Kahaly GJ. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009; 161: 11-20
• 34 Shimomura H, Nakase Y, Furuta H, Nishi M, Nakao T, Hanabusa T, Sasaki H, Okamoto K, Furukawa F, Nanjo K. A rare case of autoimmune polyglandular syndrome type 3. Diabetes Res Clin Pract 2003; 61: 103-108
• 35 Norasyikin AW, Rozita M, Mohd Johan MJ, Suehazlyn Z. Autoimmune polyglandular syndrome presenting with jaundice and thrombocytopenia. Med Princ Pract 2014; 23: 387-389
• 36 Ben-Skowronek I, Michalczyk A, Piekarski R, Wysocka-Łukasik B, Banecka B. Type III Polyglandular Autoimmune Syndromes in children with type 1 diabetes mellitus. Ann Agric Environ Med 2013; 20: 140-146
• 37 Oki K, Yamane K, Koide J, Mandai K, Nakanishi S, Fujikawa R, Kohno N. A case of polyglandular autoimmune syndrome type III complicated with autoimmune hepatitis. Endocr J 2006; 53: 705-709
• 38 Brady V, Thosani S, Zhou S, Bassett R, Busaidy NL, Lavis V. Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy. Diabetes Technol Ther 2014; 16: 874-879
• 39 Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract 2009; 15: 469-474
• 40 van Raalte DH, Ouwens DM, Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?. Eur J Clin Invest 2009; 39: 81-93
• 41 Matsumoto N, Ogawa M, Matsuoka S, Moriyama M. Prevalence and risk factors of diabetes mellitus in patients with autoimmune hepatitis. Intern Med 2016; 55: 879-885
• 42 de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett 2008; 582: 97-105
• 43 Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801
• 44 Kingston ME, Ali MA, Atiyeh M, Donnelly RJ. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology 1984; 87: 688-694
• 45 Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut 2010; 59: 1410-1415